2seventy bio Inc (NASDAQ:TSVT) shares, rose in value, with the stock price up by 0.47% to the previous day’s close as strong demand from buyers drove the stock to $4.29.
Actively observing the price movement in the last trading, the stock closed the session at $4.27. Referring to stock’s 52-week performance, its high was $12.69, and the low was $1.53. On the whole, TSVT has fluctuated by -13.51% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 78.63M, with a low estimate of 10.47M and a high estimate of 16.62M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 13.94M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TSVT’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TSVT currently trading nearly -14.98% and -15.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.12, while the 7-day volatility ratio is showing 12.05% which for the 30-day chart, stands at 9.93%. Furthermore, 2seventy bio Inc (TSVT)’s beta value is 1.90, and its average true range (ATR) is 0.49.
A comparison of 2seventy bio Inc (TSVT) with its peers suggests the former has fared considerably weaker in the market. TSVT showed an intraday change of 0.47% in last session, and over the past year, it shrunk by -50.00%%.
Data on historical trading for 2seventy bio Inc (NASDAQ:TSVT) indicates that the trading volumes over the past 3 months, they’ve averaged 1.44 million. According to company’s latest data on outstanding shares, there are 50.63 million shares outstanding.
Nearly 7.16% of 2seventy bio Inc’s shares belong to company insiders and institutional investors own 93.42% of the company’s shares. The stock has risen by 0.47% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TSVT stock heading into the next quarter.
